The cytochrome bc1 complex (complex III, cyt bc1) is an essential component of cellular respiration. Cyt bc1 has three core subunits that are required for its catalytic activity: cytochrome b, cytochrome c1, and the Rieske iron–sulfur protein (ISP). Although most fungicides inhibit this enzyme by binding to the cytochrome b subunit, resistance to these fungicides has developed rapidly due to their widespread application. Resistance is mainly associated with mutations in cytochrome b, the only subunit encoded by mitochondrial DNA. Recently, the flexibility and motion of the ISP and its essential role in electron transfer have received intense attention; this leads us to propose a new classification of cyt bc1 inhibitors (three types of Qo inhibitors) that mobilize, restrict, or fix the rotation of the ISP. Importantly, the strengths of the ISP–inhibitor interactions correlate with inhibitor activity and the development of resistance to Qo inhibitors, thereby offering clues for designing novel cyt bc1 inhibitors with high potency and a low risk of resistance.